On the issue of the potential continuation of EPO appeal proceedings by an intervener the questions for referral on which we already reported
Continue reading
In the opposition appeal proceedings “T1286/23”, which we had already reported on “
Continue reading
As part of our regular internal legal seminars, Dr. Wilhelm Eger held a talk on current developments in infringement under the doctrine of equivalency in various European lega...
Continue reading
All articles
New York, NY, February 12, 2025 – Royalty Pharma (Nasdaq: RPRX) has entered into an agreement with Biogen to provide up to $250 million in research and development (R&D) funding for litifilimab, a first-in-class investigational biologic in Phase 3 tria...
Continue reading
The European Patent Office (EPO) was expected to issue key rulings on CRISPR/Cas9 patents this autumn, but instead, legal uncertainty persists. Nobel Prize winners Emmanuelle Charpentier and Jennifer Doudna, pioneers of the technology, withdrew their patent applications befo...
Continue reading
The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...
Continue reading
Maiwald in the press
Dr. Anna Closs specializes in intellectual prope...
Continue reading
Effective January 1, 2025, Maiwald, one of Germany's leading intellectual property law firms, appointed two new Counsel, Dr. Lukas Delvos and Dr. Jian Sun. Lukas Delvos until ...
Continue reading
All Staff News
This article discusses some aspects that arose as a direct or indirect consequence of the entry into force of the Unified Patent Court (UPC) Agreement on 1 June 2023 at German...
Continue reading
In their recent publication in Managing IP, Dr. Eva Ehlich and Dr. Anja Fux discuss a board of appeal decision on G 2/21’s interpretation, including a critical review of the...
Continue reading
All publications
At Maiwald, we go to great lengths to ensure that all our colleagues feel comfortable and are constantly trying to optimize ourselves in order to achieve and maintain the most...
Continue reading
We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders: Dr. Andreas Ledl...
Continue reading
All awards
Thu.
20
Join Donjing son, Alexander Feil and Dr.-Ing. Sophie Ertl at IPBC Korea 2025 on 20 February in Seoul! This premier event will bring together industry leaders to discuss the latest trends and challenges in intellectual property. With a fully bilingual agenda, it’s the perfect opportunit...
Continue reading
Fri.
21
Patents, trademarks and design - Property rights, processes and strategies At the Ingolstadt Patent Day, patent experts, employees from patent and legal departments, representatives from law firms as well as students and graduat...
Continue reading
Tue.
11
Empowering Women to Lead with Vision and Purpose The inaugural European Summit for Women Leaders in Life Sciences Law brings together professionals from biotech, pharma, and medical devices to discuss and develop solutions to their common challenges. T...
Continue reading
Thu.
13
On March 13, 2025 our parter Dr. Marco Stief will give a talk at the 28th Marburger Discussions on Pharmaceutical Law (Forschungsstelle für Pharmarecht) on marketing protection under patent law, which will also cover the limits and procedural enforcement as well as the associated legal consequenc...
Continue reading
All events